IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children

$2,300,000U01FY2023IPCDC

Children'S Mercy Hosp (Kansas City, Mo), Kansas City MO

Investigators

Rangaraj Selvarangancontact Jennifer E Schuster

Linked publications, trials & patents

View original record on NIH RePORTER →

IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children · GrantIndex